ASX:CSL CSL (CSL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About CSL Stock (ASX:CSL) 30 days 90 days 365 days Advanced Chart Get CSL alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume869,289 shsAverage VolumeN/AMarket CapitalizationA$77.43 billionP/E Ratio28.02Dividend Yield1.56%Price TargetN/AConsensus RatingN/A Company Overview CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia. Read More Receive CSL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter. Email Address CSL Stock News HeadlinesBMW M Plans A Flagship ‘Dream Car’ For CollectorsJuly 3 at 6:22 PM | msn.comHere are the latest growth forecasts for the CSL share priceJuly 3 at 5:11 AM | msn.comThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.July 4 at 2:00 AM | Brownstone Research (Ad)BMW M4 CSL with Modified Exhaust – Brutal Accelerations & Downshifts!July 3 at 5:11 AM | msn.comChinese football club's bus seized over unpaid debts, players forced to ride bicycle homeJuly 1 at 10:04 AM | msn.comCSL to build two tugs for Polestar Maritime LtdJune 30, 2025 | msn.comNow trading at an 'attractive price', why CSL shares look set for a reboundJune 29, 2025 | msn.comBMW M3 CSL E46 vs VW Bora VR6 – ¼ Mile Drag Race | Acceleration & Sound Battle (Viertelmeile Rennen)June 29, 2025 | msn.comSee More Headlines CSL Stock Analysis - Frequently Asked Questions How were CSL's earnings last quarter? CSL Limited (ASX:CSL) posted its quarterly earnings results on Wednesday, August, 14th. The company reported $4.24 earnings per share for the quarter, beating analysts' consensus estimates of $4.22 by $0.01. CSL had a net margin of 18.41% and a trailing twelve-month return on equity of 15.37%. What other stocks do shareholders of CSL own? Based on aggregate information from My MarketBeat watchlists, some other companies that CSL investors own include Cochlear (COH), Mineral Resources (MIN), ResMed (RMD), Magellan Financial Group (MFG), NIB (NHF), Accent Group (AX1) and Corporate Travel Management (CTD). Company Calendar Last Earnings8/14/2019Ex-Dividend for 4/8 Dividend3/09/2025Record date for 4/8 Dividend4/08/2025Dividend Payable4/08/2025Today7/04/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryRubber And Plastic Products Current SymbolASX:CSL CIKN/A Webwww.csl.com.au Phone+61-3-93891911FaxN/AEmployees12,500Year FoundedN/AProfitability EPS (Trailing Twelve Months)A$7.88 Trailing P/E Ratio28.02 Forward P/E RatioN/A P/E Growth1.29Net IncomeA$2.64 billion Net Margins18.41% Pretax MarginN/A Return on Equity15.37% Return on Assets6.56% Debt Debt-to-Equity Ratio64.46 Current Ratio1.86 Quick Ratio1.68 Sales & Book Value Annual SalesA$14.80 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow207.70 Book ValueA$42.52 per share Price / BookN/AMiscellaneous Outstanding Shares484,210,000Free FloatN/AMarket CapA$77.43 billion OptionableNot Optionable Beta0.32 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (ASX:CSL) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CSL Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share CSL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.